Laboratory evaluation of a novel capillary blood sampling device for measuring eight clinical chemistry parameters and HbA1c

被引:31
作者
Gootjes, Jeannette [1 ]
Tel, Rense M. [1 ]
Bergkarnp, Ferry J. M. [1 ]
Gorgels, Jozef R. M. C. [1 ]
机构
[1] Med Med Diagnost Lab, NL-2134 TM Hoofddorp, Netherlands
关键词
Blood-sampling; Capillary blood; Demecal; Self-management; Self-testing; Method-comparison;
D O I
10.1016/j.cca.2008.12.016
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The Demecal set enables medically unskilled persons to produce diluted plasma from a single drop of capillary blood at any time and place. The sample is mailed to a certified laboratory for analysis. A marker compound in the dilution buffer enables to correct for individual blood sampling variation. A test dependent factor corrects for recovery of analytes. Methods: Glucose, cholesterol, triglycerides, HDL and LDL cholesterol, creatinine, BUN, uric acid and HbA1c were evaluated. We studied the correction procedure for sampling variation by the marker compound, the precision of the analyzer in the low range, the influence of characteristics of the set on analyte recovery, and the stability of the samples at different temperatures. Results: Using the marker compound in the buffer, variation in sampling could be corrected accurately. For dilutions up to 15 times, the precision of the analyzer was sufficient. Application of test specific recovery factors gave a good correlation with results of venous blood samples. Samples were stable for 4 days at 4 degrees C. 2-3 days at room temperature and I day at 37 degrees C. Conclusions: The Demecal set can be considered an alternative for venous blood sampling for the tested parameters, enabling patient friendly management of chronic disease. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:152 / 157
页数:6
相关论文
共 12 条
[1]   Compliance and adherence are dysfunctional concepts in diabetes care [J].
Anderson, RM ;
Funnell, MM .
DIABETES EDUCATOR, 2000, 26 (04) :597-+
[2]  
BRAUN S, 2008, ANAL BIOANAL CH 0622
[3]  
DEROOIJ FX, 2000, Patent No. 1021715
[4]  
DEROOIJ FX, 2001, Patent No. 6245244
[5]   DIABETES MANAGEMENT - THE IMPORTANCE OF PATIENT EDUCATION AND PARTICIPATION [J].
ETZWILER, DD .
POSTGRADUATE MEDICINE, 1986, 80 (06) :67-&
[6]  
Hibbard JH, 2003, MED CARE, V41, pI61
[7]  
HIROMI N, 2002, Patent No. 1221614
[8]   Therapeutic drug monitoring of tacrolimus with the dried blood spot method [J].
Hoogtanders, K. ;
van der Heijden, J. ;
Christiaans, M. ;
Edelbroek, P. ;
van Hooff, J. P. ;
Stolk, L. M. L. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 44 (03) :658-664
[9]   Bloodspot assay using HPLC-tandem mass spectrometry for detection of Barth syndrome [J].
Kulik, Willem ;
van Lenthe, Henk ;
Stet, Femke S. ;
Houtkooper, Riekelt H. ;
Kemp, Helena ;
Stone, Janet E. ;
Steward, Colin G. ;
Wanders, Ronald J. ;
Vaz, Frederic M. .
CLINICAL CHEMISTRY, 2008, 54 (02) :371-378
[10]   DIFFERENCES BETWEEN CAPILLARY AND VENOUS-BLOOD GLUCOSE DURING ORAL GLUCOSE-TOLERANCE TESTS [J].
LARSSONCOHN, U .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1976, 36 (08) :805-808